Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey
Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey
复制标题
DOI：
10.1158/1055-9965.epi-12-0343
复制
发表时间：
2012-07-01
影响因子：
3.8
通讯作者：
Marcus, Pamela M.
中科院分区：
文献类型：
--
作者：
Doria-Rose, V. Paul;White, Mary C.;Marcus, Pamela M.
背景：在有证据证明疗效之前，许多医生都要求进行肺癌筛查。国家肺部筛查试验(NLST)显示，在随机接受低剂量计算机断层扫描(LDCT)的人中，肺癌死亡率降低了20%，这可能会导致筛查使用率的增加。方法：我们使用2010年全国健康访谈调查(NHIS)的数据估计了美国胸部X光和CT使用的流行率。受试者包括15,537名NHIS受访者，年龄=40岁，之前没有肺癌的诊断。计算了按年龄和吸烟状况对美国人口规模的估计。结果：23%的成年人报告了上一年的胸部X光检查，2.5%的成年人报告了专门检查肺癌的胸部X光检查；胸部CT的相应数字分别为7.5%和1.3%。年龄较大、黑人种族、男性、吸烟、呼吸系统疾病、个人癌症病史和有医疗保险与测试使用有关。根据NLST的资格标准，大约有870万美国成年人有资格接受LDCT筛查。结论和影响：监测肺部筛查测试的使用趋势将对评估NLST的影响以及未来肺癌筛查建议和保险覆盖范围的可能变化至关重要。医生和普通公众对患者的教育可能有助于确保对最有可能受益的患者进行适当的筛查。癌症流行病学生物标志物；21(7)；1049-59。(C)2012年AACR。
Background: Before evidence of efficacy, lung cancer screening was being ordered by many physicians. The National Lung Screening Trial (NLST), which showed a 20% reduction in lung cancer mortality among those randomized to receive low-dose computed tomography (LDCT), will likely lead to increased screening use.Methods: We estimated the prevalence of chest X-ray and CT use in the United States using data from the 2010 National Health Interview Survey (NHIS). Subjects included 15,537 NHIS respondents aged >= 40 years without prior diagnosis of lung cancer. Estimates of the size of the U. S. population by age and smoking status were calculated. Multivariate logistic regression examined predictors of test use adjusting for potential confounders.Results: Twenty-three percent of adults reported chest X-ray in the previous year and 2.5% reported chest X-ray specifically to check for lung cancer; corresponding numbers for chest CT were 7.5% and 1.3%. Older age, black race, male gender, smoking, respiratory disease, personal history of cancer, and having health insurance were associated with test use. Approximately, 8.7 million adults in the United States would be eligible for LDCT screening according to NLST eligibility criteria.Conclusions and Impact: Monitoring of trends in the use of lung screening tests will be vital to assess the impact of NLST and possible changes in lung cancer screening recommendations and insurance coverage in the future. Education of patients by their physicians, and of the general public, may help ensure that screening is used appropriately, in those most likely to benefit. Cancer Epidemiol Biomarkers Prev; 21(7); 1049-59. (C)2012 AACR.